Development of monetite/phosphorylated chitosan composite bone cement

J Biomed Mater Res B Appl Biomater. 2014 Feb;102(2):260-6. doi: 10.1002/jbm.b.33003. Epub 2013 Aug 30.

Abstract

In this article, we report the development of a biodegradable monetite [dicalcium phosphate anhydrous (DCPA), CaHPO4 ]/phosphorylated chitosan (p-chitosan) composite orthopedic cement. The cement pastes showed desirable handling properties, injectability, and washout resistance. The incorporation of p-chitosan powders at 5 wt % shortened the setting time of DCPA and significantly improved the mechanical performance of DCPA cement, increasing the compressive strength almost twice from 11.09 ± 1.85 MPa at 0% chitosan to 23.43 ± 1.47 MPa at 5 wt % p-chitosan. On the other hand, higher p-chitosan content or untreated chitosan incorporation lowered the performance of DCPA cements. The cytocompatibility of the composite cement was investigated in vitro using the preosteoblast cell line MC3T3-E1. An increase in cell proliferation was observed in both DCPA and DCPA-p-chitosan. The results show that both the materials are as cytocompatible as hydroxyapatite. Based on these results, DCPA-p-chitosan composite cement can be considered as potential bone repair material.

Keywords: bone cement; chitosan; composite; monetite.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Bone Cements / chemistry*
  • Calcium Phosphates / chemistry*
  • Cell Line
  • Chitosan / chemistry*
  • Materials Testing*
  • Mice

Substances

  • Bone Cements
  • Calcium Phosphates
  • Chitosan
  • calcium phosphate, dibasic, anhydrous